版本:
中国

AcelRx pain drug found safe in high-risk patients in late-stage study

Sept 15 AcelRx Pharmaceuticals Inc said its experimental pain drug was well tolerated in post-operative patients, including those with organ impairment and the elderly, in a late-stage study.

The opioid-based treatment, ARX-04, is being developed for patients experiencing moderate to severe acute pain following a surgical procedure. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Maju Samuel)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐